Researchers at the University of Central Florida have developed a screening technique that is 300 times more sensitive at detecting a biomarker for colorectal cancer than current methods. The technique uses nanoparticles with nickel-rich cores and platinum-rich shells to increase the sensitivity of an enzyme-linked immunosorbent assay (ELISA), a test which measures samples for biochemicals that indicate the presence of cancer, HIV, and pregnancy.
An official website of the United States government.